Sign in

CIK 0001321834 · Non-accelerated filer<br>Smaller reporting company

Q/C TECHNOLOGIES, INC.

Sign in to watch
Ticker
QCLS
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
856-848-8698
Business address
1185 AVENUE OF THE AMERICAS, SUITE 249, NEW YORK, NY, 10036
Former names
Q/C TECHNOLOGIES, INC., TNF Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Akers Biosciences, Inc., Akers Biosciences Inc
  1. 8-K Event Delisting notice · Regulation FD disclosure
  2. 8-K Event Other events
  3. NT 10-Q Other NT 10-Q
  4. SC 13G/A Stake Amended Statement of Ownership
  5. 8-K Event Executive or director change
  6. 4/A Insider Changes in Ownership
  7. 4/A Insider Changes in Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 10-K Report Annual Report
  11. NT 10-K Other NT 10-K
  12. SC 13G/A Stake Amended Statement of Ownership
  13. SC 13G Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G Stake Amended Statement of Ownership
  16. UPLOAD Other SEC-generated Letter
  17. 8-K Event Bylaws or fiscal year change · Other events
  18. SC 13G Stake Amended Statement of Ownership
  19. 424B4 Offering Prospectus
  20. 8-K Event Material agreement · Other events

Page 23 of 31 · 604 filings